(Q35098745)

6 August 2017

1 reference

title

Medical therapy of Cushing's disease (English)

1 reference

6 August 2017

1 reference

Lynnette K Nieman

1

1 reference

6 August 2017

1 January 2002

1 reference

6 August 2017

1 reference

6 August 2017

5

1 reference

6 August 2017

2

1 reference

6 August 2017

77-82

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022308429992

6 August 2017

0 references

cites work

Follow-up study on treatment in 27 patients with Cushing's disease: Adrenalectomy, transsphenoidal adenomectomy and medical treatment

1 reference

12 December 2020

Successful control of Cushing's disease in the elderly with long term metyrapone

1 reference

12 December 2020

Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo

1 reference

12 December 2020

Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease

1 reference

12 December 2020

Lack of Effect of Antiserotoninergic and/or Dopaminergic Treatment in Patients with Pituitary-Dependent Cushing's Syndrome

1 reference

12 December 2020

Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis

1 reference

12 December 2020

Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.

1 reference

12 December 2020

Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation

1 reference

12 December 2020

AN EFFECT OF O,P'-DDD ON THE EXTRA-ADRENAL METABOLISM OF CORTISOL IN MAN.

1 reference

12 December 2020

Trilostane, an orally active inhibitor of steroid biosynthesis

1 reference

12 December 2020

Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome

1 reference

12 December 2020

Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome

1 reference

12 December 2020

Octreotide exerts different effects in vivo and in vitro in Cushing's disease

1 reference

12 December 2020

Ketoconazole inhibits corticotropic cell function in vitro

1 reference

12 December 2020

Aminoglutethimide: review of pharmacology and clinical use.

1 reference

12 December 2020

More on cyproheptadine

1 reference

12 December 2020

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

1 reference

12 December 2020

In vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome

1 reference

12 December 2020

Aminoglutethimide and metyrapone in the management of Cushing's syndrome

1 reference

12 December 2020

Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary

1 reference

12 December 2020

Complete remission of Nelson's syndrome after 1-year treatment with cabergoline

1 reference

12 December 2020

The use of ketoconazole as an inhibitor of steroid production

1 reference

12 December 2020

The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease

1 reference

12 December 2020

Metyrapone in long-term management of Cushing's disease

1 reference

12 December 2020

Experience with trilostane in the treatment of Cushing's syndrome

1 reference

12 December 2020

RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day

1 reference

12 December 2020

Ketoconazole therapy in Cushing's disease

1 reference

12 December 2020

Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.

1 reference

12 December 2020

Metyrapone Is Useful Only as Adjunctive Therapy in Cushing's Disease

1 reference

12 December 2020

Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy

1 reference

12 December 2020

Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production

1 reference

12 December 2020

1 reference

12 December 2020

Aminoglutethimide in the treatment of Cushing's syndrome

1 reference

12 December 2020

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

1 reference

12 December 2020

Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis

1 reference

12 December 2020

Effect of aminoglutethimide on urinary cortisol and cortisol metabolites in adolescents with Cushing's syndrome

1 reference

12 December 2020

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

1 reference

12 December 2020

Studies on the site of action of o,p'-DDD in the dog adrenal cortex. II. TPNH- and corticosteroid precursor-stimulation of o,p'-DDD inhibited steroidogenesis.

1 reference

12 December 2020

Efficacy of amino-glutethimide in the ectopic ACTH syndrome

1 reference

12 December 2020

Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells

1 reference

12 December 2020

The medical treatment of Cushing's syndrome

1 reference

12 December 2020

Effects of amino-glutethimide on adrenal function in man.

1 reference

12 December 2020

[The effects of o,p'-DDD on adrenal steroidogenesis and hepatic steroid metabolism]

1 reference

12 December 2020

Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism

1 reference

12 December 2020

The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo

1 reference

12 December 2020

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

1 reference

12 December 2020

The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome

1 reference

12 December 2020

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

1 reference

12 December 2020

Hepatic microsomal enzyme induction and adrenal crisis due to o,p'DDD therapy for metastatic adrenocortical carcinoma

1 reference

12 December 2020

Cyproheptadine-Induced Remission of Cushing's Disease

1 reference

12 December 2020

Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing's disease before and after ketoconazole treatment

1 reference

12 December 2020

Effects of Aminoglutethimide Upon Adrenal Function and Cortisol Metabolism in Cushing's Syndrome

1 reference

12 December 2020

Primary therapy for Cushing's disease with metyrapone

1 reference

12 December 2020

Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).

1 reference

12 December 2020

Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients

1 reference

12 December 2020

Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases

1 reference

12 December 2020

Therapy of Cushing's syndrome with steroid biosynthesis inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022308429992

1 reference

PubMed ID

12675504

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12675504